Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yawen Fan

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|April 15, 2025
Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate CancerWenqiang Zhang, Hao Zhu, Zhuolin Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patientsWende Hao, Xuhui Zhang, Bingshui Xiu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 14, 2016
Non-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopyRui Xiao, Xuhui Zhang, Zhen Rong, et al.
Journal of Medicinal Chemistry|December 21, 2023
Discovery of (2<i>S</i>)-<i>N</i>-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia TreatmentWenqiang Zhang, Siqi Zhao, Yi Luo, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|April 15, 2025
Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate CancerWenqiang Zhang, Hao Zhu, Zhuolin Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patientsWende Hao, Xuhui Zhang, Bingshui Xiu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 14, 2016
Non-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopyRui Xiao, Xuhui Zhang, Zhen Rong, et al.
Journal of Medicinal Chemistry|December 21, 2023
Discovery of (2<i>S</i>)-<i>N</i>-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia TreatmentWenqiang Zhang, Siqi Zhao, Yi Luo, et al.
Pageof 5